United States Últimas notícias

Gamehaus Holdings (NASDAQ:GMHS) reported its unaudited financial results for the third quarter of fiscal year 2026, ended March 31, 2026.

American Battery Technology Company (NASDAQ:ABAT) announced today that it has successfully won its appeal with the U.S. Department of Energy (DOE) regarding the reinstatement of a competitive grant award.

Duluth Holdings (NASDAQ:DLTH) reported financial results for the first quarter of fiscal 2026, ended May 3, 2026, highlighting significant progress in operational efficiency despite a challenging retail environment.

UK AI & Online Safety Minister Kanishka Narayan joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg's The Pulse.

Marija Veitmane, equity research head at State Street Global Markets, discusses the artificial intelligence trade and how Middle East peace prospects impact European stocks. While an end to war and lower energy costs would benefit Europe, "it needs to come with a cyclical earnings recovery and we're just not there yet," Veitmane says on Bloomberg Television.

Multiverse CEO & Founder Euan Blair joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg's The Pulse.

Advanced Micro Devices (NASDAQ:AMD) announced plans to invest up to £2 billion in the United Kingdom over the next five years, a strategic move designed to accelerate AI innovation, scientific research, and technical workforce development.

Alvotech (NASDAQ:ALVO) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration.

Visionaries General Partner Judith Dada joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg's The Opening Trade.

LENZ Therapeutics (NASDAQ:LENZ) and Everest Medicines announced an agreement on June 8, 2026, transferring the rights to develop, manufacture, and commercialize LNZ100—marketed in the United States as VIZZ—within Greater China.

Nurix Therapeutics (NASDAQ:NRIX) announced on June 8, 2026, that it has entered into a global licensing and collaboration agreement with Roche to co-develop and co-commercialize bexobrutideg (NX-5948).

HSBC Chief Executive Officer Georges Elhedery says that while certain roles will be displaced by artificial intelligence, the productivity gains can be reinvested. "I would like to be able to accelerate and bring forward a lot of the ambitious deliverables we have for the future," Elhedery tells Bloomberg's Francine Lacqua. "That requires investment, and that is job creation."